News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Drug Regulator Asks Sun Pharmaceutical Industries Ltd to Halt Clinical Research at Mumbai Laboratory



11/11/2013 7:36:21 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

The Drug Controller General of India has ordered Sun Pharmaceutical, the country's largest drug maker by market capitalisation, to suspend clinical research activities at its Mumbaibased bio-analytical laboratory, a move that could slow down the company's regulatory filings in India and possibly overseas as well. According to officials familiar with the matter, the drug regulator took the step after discovering that Sun didn't have the requisite approval from the central government for operating the laboratory. The drug regulator has decided not to accept future applications and won't process existing new drug filings that Sun has made from the Mumbai lab until the company gets an approval.

Help employers find you! Check out all the jobs and post your resume.



comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES